Pancreatic Neoplasms: all 3,311 studies
Page 20 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Personalized Precision Diagnosis and Treatment of Pancreatic CancerStatus unknownNCT04373928Not applicable
- Preoperative Inflammatory Biomarkers and Postoperative Day 1 Drain Amylase Value Predict Pancreatic Fistula After PancreaticoduodenectomyCompletedNCT04361682
- Nivolumab + Ipilimumab + Radiation in MSS Pancreatic CancerActive, not recruitingNCT04361162Phase 2
- Effect of Thrombin-containing Collagen-based Hemostatic MatrixStatus unknownNCT04357483Phase 4
- Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ CancerWithdrawnNCT04348643Phase 1/2
- Trainee Involvement in ERCP Risk ScoreCompletedNCT04341909
- Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerActive, not recruitingNCT04340141Phase 3
- Portal Vein Resection in Pancreatic Neuroendocrine TumoursStatus unknownNCT04336839
- Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas AdenocarcinomaActive, not recruitingNCT04331041Phase 2
- Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersCompletedNCT04330716Not applicable
- Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic PotentialStatus unknownNCT04323917
- The Italian Version of Cancer Worry ScaleStatus unknownNCT04318756
- Multivisceral Resection in Distal PancreatectomyCompletedNCT04317352
- Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer PatientsStatus unknownNCT04316507Not applicable
- A Novel Patient Engagement Platform Among Patients With Gastrointestinal MalignanciesCompletedNCT04316078Not applicable
- An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT04310553Not applicable
- EUS-RFA for Unresectable Pancreatic CancerCompletedNCT04310111Not applicable
- A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyTerminatedNCT04300114Phase 3
- Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic CancerCompletedNCT04293497Not applicable
- Early Palliative Care in Pancreatic Cancer - a Quasi-experimental StudyCompletedNCT04290364
- A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving ChemotherapyCompletedNCT04281511
- Feasibility Study of LUM Imaging System for Pancreatic CancerWithdrawnNCT04276909Not applicable
- Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the PancreasActive, not recruitingNCT04275557
- The Microbiome of Pancreatic Cancer: "PANDEMIC" StudyStatus unknownNCT04274972
- Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic CarcinomaWithdrawnNCT04270929Phase 1
- Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated PatientsStatus unknownNCT04269369Phase 4
- Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo PlateformCompletedNCT04263948Not applicable
- Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
- Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic CancerTerminatedNCT04258150Phase 2
- Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.Status unknownNCT04258072Phase 1
- COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncerCompletedNCT04257955
- Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic CancerCompletedNCT04257448Phase 1/2
- Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.CompletedNCT04247165Phase 1/2
- Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy SamplesActive, not recruitingNCT04246710
- Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic CancerActive, not recruitingNCT04246203
- Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS StudyActive, not recruitingNCT04245644
- A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic CancerActive, not recruitingNCT04241276Phase 2
- Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic CancerStatus unknownNCT04239001Not applicable
- The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT):CompletedNCT04237441
- Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadActive, not recruitingNCT04233866Phase 2
- A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic CancerCompletedNCT04229004Phase 3
- A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic CancerCompletedNCT04228601Phase 1/2
- Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.CompletedNCT04224402Phase 2
- Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer PatientsStatus unknownNCT04217096Phase 4
- Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.TerminatedNCT04212026Phase 2
- Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid TreatmentCompletedNCT04210128
- L-DOS47 Plus Doxorubicin in Advanced Pancreatic CancerTerminatedNCT04203641Phase 1/2
- The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota RegulationStatus unknownNCT04203459
- Surgery for Pancreatic Cancer With Oligo-MetastasisCompletedNCT04196816
- Pancreatic Cancer and Carbon Ion RadiotherapyCompletedNCT04194268Not applicable
- A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic CancerTerminatedNCT04193904Phase 1
- Pharmacokinetics of Apixaban in Patients Undergoing PancreaticoduodenectomyCompletedNCT04191928Phase 1
- The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic CancerStatus unknownNCT04183478Phase 2/3
- SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic CancerCompletedNCT04181645Not applicable
- Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerSuspendedNCT04172532Phase 1/2
- Prospective Study FNB, Is It Time To Abandon Cytological AssessmentCompletedNCT04165018
- Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic LesionsStatus unknownNCT04164017Not applicable
- Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With SurgeryActive, not recruitingNCT04161755Phase 1
- Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic CancerSuspendedNCT04158635Phase 1
- Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic CancerCompletedNCT04156087Phase 2
- An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic CancerWithdrawnNCT04151719Phase 3
- Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
- Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
- Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic CancerNo longer availableNCT04137822
- A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic CancerActive, not recruitingNCT04137536Phase 1
- Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic CancerTerminatedNCT04136769Not applicable
- Usefulness of the Artery First Approach in Pancreatic Cancer SurgeryStatus unknownNCT04136522Not applicable
- Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic CancerCompletedNCT04133155
- Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic CancerCompletedNCT04132505Phase 1
- Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic CancerTerminatedNCT04131192Phase 1
- Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic CancerWithdrawnNCT04130399Phase 2
- Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic CancerCompletedNCT04128332Not applicable
- A Pilot Study of BXCL701 in Patients With Pancreatic CancerWithdrawnNCT04123574Early Phase 1
- Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic CancersTerminatedNCT04117958Phase 1
- Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic CancerActive, not recruitingNCT04117087Phase 1
- Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic CancerActive, not recruitingNCT04115163Phase 2
- Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic CancerStatus unknownNCT04112836
- A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal AdenocarcinomaSuspendedNCT04111172Phase 2
- Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic CancerStatus unknownNCT04110769Not applicable
- Usefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer PatientsCompletedNCT04109495Not applicable
- Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic CancerCompletedNCT04106856Phase 1
- Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyTerminatedNCT04106167
- A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal MalignanciesCompletedNCT04104672Phase 1
- Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG RegimenStatus unknownNCT04101929Phase 2
- 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic AdenocarcinomaActive, not recruitingNCT04098081Phase 2
- Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic CancerStatus unknownNCT04093141Not applicable
- IORT on Borderline Resectable Pancreatic CancerSuspendedNCT04090463Phase 2
- MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced DiseaseStatus unknownNCT04089150Phase 2
- Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic CancerNo longer availableNCT04087889
- Fine Needle Biopsy of Solid Pancreatic Mass LesionsStatus unknownNCT04085055Not applicable
- A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic CancerWithdrawnNCT04083651Phase 2/3
- Carbon Ion Radiotherapy for Locally Advanced Pancreatic CancerActive, not recruitingNCT04082455Not applicable
- A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic CancerCompletedNCT04080024Phase 1
- A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in TaiwanTerminatedNCT04070313Phase 2
- Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
- ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic CancerCompletedNCT04064034Not applicable
- Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic CancerWithdrawnNCT04058964Phase 2
- Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT04054362Phase 2
- Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.OrgCompletedNCT04053998
- SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic CancerCompletedNCT04050085Phase 1